Not applicableStudy completedNCT02519413What this trial is testingTecfidera Lymphocyte Chart ReviewWho this might be right forMultiple Sclerosis Biogen 483
Large-scale testing (Phase 3)Study completedNCT00662649What this trial is testingLong-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisWho this might be right forMultiple Sclerosis Novartis 920
Large-scale testing (Phase 3)Not Yet RecruitingNCT07189325What this trial is testingA Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple SclerosisWho this might be right forRelapsing-Remitting Multiple Sclerosis (RRMS)Anti-CD20 Therapy University Hospital, Montpellier 250
Testing effectiveness (Phase 2)Study completedNCT00489489What this trial is testingPhase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple SclerosisWho this might be right forMultiple Sclerosis Sanofi 118
Post-approval studies (Phase 4)Study completedNCT02048072What this trial is testingEvaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MSWho this might be right forMultiple SclerosisAutonomic Nervous System Dysfunction Jochen Vehoff 33
Not applicableLooking for participantsNCT06586177What this trial is testingUnderstanding the 'Durable Effect' Concept of B-cell Modulating TherapiesWho this might be right forRelapsing-remitting Multiple Sclerosis Heinrich-Heine University, Duesseldorf 100
Post-approval studies (Phase 4)UnknownNCT04048577What this trial is testingA Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of NatalizumabWho this might be right forMultiple SclerosisMultiple Sclerosis, Relapsing-Remitting Berkovich, Regina MD, PhD Inc. 10
Not applicableStudy completedNCT04115930What this trial is testingCorrelation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS PatientsWho this might be right forRelapsing Remitting Multiple SclerosisFatigueQuality of Life+1 more University of Eastern Finland 61
Post-approval studies (Phase 4)Study completedNCT03385356What this trial is testingImpact of Vitamin D Supplementation in Patients With Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-RemittingVitamin D Deficiency University Medical Centre Maribor 89
Testing effectiveness (Phase 2)Ended earlyNCT03183869What this trial is testingFecal Microbial Transplantation in Relapsing Multiple Sclerosis PatientsWho this might be right forAutoimmune DiseasesRelapsing Multiple Sclerosis London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 14
Large-scale testing (Phase 3)Temporarily pausedNCT05441488What this trial is testingMasitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple SclerosisWho this might be right forProgressive Multiple Sclerosis AB Science 800
Early research (Phase 1)Looking for participantsNCT07224373What this trial is testingAn Open-label Study of AZD0120 in Adults With Multiple SclerosisWho this might be right forMultiple Sclerosis AstraZeneca 24
Not applicableUnknownNCT03787446What this trial is testingPET Study in Multiple SclerosisWho this might be right forMultiple Sclerosis University of British Columbia 9
Testing effectiveness (Phase 2)Study completedNCT03381170What this trial is testingAn Extension of the TG1101-RMS201 TrialWho this might be right forRelapsing Remitting Multiple Sclerosis TG Therapeutics, Inc. 48
Not applicableStudy completedNCT02021162What this trial is testingEffects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple SclerosisWho this might be right forMultiple SclerosisHealthy University at Buffalo 50
Not applicableStudy completedNCT01142492What this trial is testingA Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)Who this might be right forRelapsing-Remitting Multiple Sclerosis Merck KGaA, Darmstadt, Germany 403
Not applicableStudy completedNCT04832399What this trial is testingStudy of Tysabri in Early Relapsing Remitting Multiple Sclerosis ParticipantsWho this might be right forRelapsing Remitting Multiple Sclerosis Biogen 60
Not applicableStudy completedNCT01281657What this trial is testingLong Term Study of Fingolimod in MS Patients From the FTY Clinical ProgramWho this might be right forMultiple Sclerosis Novartis 64
Not applicableStudy completedNCT00594087What this trial is testingEszopiclone for Improving Sleep in Multiple Sclerosis (MS)Who this might be right forRelapsing Remitting Multiple SclerosisSleep Initiation and Maintenance DisordersFatigue University of Vermont 30
Testing effectiveness (Phase 2)Study completedNCT03889639What this trial is testingDose-finding Study for SAR442168 in Relapsing Multiple SclerosisWho this might be right forRelapsing Multiple Sclerosis Sanofi 130